Valuation: Biogen Inc.

Market Cap 29.12B 25.46B 23.49B 21.59B 40.91B 2,802B 41.61B 280B 110B 1,370B 109B 107B 4,720B P/E 2026 *
23.4x
P/E 2027 * 15.8x
Enterprise Value 34.69B 30.33B 27.98B 25.72B 48.73B 3,338B 49.57B 334B 131B 1,632B 130B 127B 5,624B EV / Sales 2026 *
3.44x
EV / Sales 2027 * 3.14x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+2.76%
1 week-1.56%
Current month-8.71%
1 month-0.70%
3 months+9.25%
6 months+17.01%
Current year+12.07%
1 week 186.02
Extreme 186.025
210.87
1 month 186.02
Extreme 186.025
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
281.12
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Director

1,505 0.0010%
09/06Free

Director

1,505 0.0010%
09/06Free

Chairman

2,005 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
+2.76%-1.56%+54.70%-29.29% 29.12B
+1.27%+0.24%+21.26%-7.53% 67.6B
-0.72%-6.36%+37.99%+192.04% 51.32B
+1.10%+38.30%+38.30%+38.30% 42.97B
+0.16%-2.85%-50.72%-52.88% 40.81B
+1.25%-7.48%+116.21%-43.73% 27.09B
+0.18%-1.85%+68.63%+86.35% 22.99B
-2.94%+9.09%+9.28%+199.05% 21.55B
+3.75%-1.42%+66.78%+129.35% 16.38B
-1.70%+5.53%+76.00%+353.68% 16.2B
Average +0.52%+0.00%+43.84%+86.53% 33.6B
Weighted average by Cap. +0.58%-0.47%+35.14%+62.26%

Financials

2026 *2027 *
Net sales 10.09B 8.82B 8.14B 7.48B 14.17B 971B 14.42B 97.15B 38.12B 475B 37.89B 37.06B 1,636B 10.36B 9.06B 8.35B 7.68B 14.55B 997B 14.8B 99.74B 39.14B 487B 38.9B 38.05B 1,679B
Net income 1.36B 1.19B 1.1B 1.01B 1.91B 131B 1.95B 13.12B 5.15B 64.06B 5.12B 5B 221B 1.95B 1.7B 1.57B 1.44B 2.74B 188B 2.78B 18.77B 7.36B 91.66B 7.32B 7.16B 316B
Net Debt 5.57B 4.87B 4.49B 4.13B 7.83B 536B 7.96B 53.65B 21.05B 262B 20.92B 20.47B 903B 3.44B 3B 2.77B 2.55B 4.83B 331B 4.91B 33.09B 12.99B 162B 12.91B 12.62B 557B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
15/07/26 USD 197.24 +2.76% 2,067,350
14/07/26 USD 191.95 -8.17% 3,902,309
13/07/26 USD 209.03 +4.96% 2,259,821
10/07/26 USD 199.15 +0.12% 1,133,120
09/07/26 USD 198.91 -0.72% 1,657,327
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
197.24USD
Average target price
225.45USD
Spread / Average Target
+14.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock